Skip to main content
OpenTrials
Completed

NCT Number: NCT01174524

Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme

The purpose of this study is to determine whether low-dose contraceptive pills are effective in the improvement of quality of life in patients in the different phases of menacme.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–46 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Hospital Geral de Fortaleza

Fortaleza, Ceará, 60115290, Brazil

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fertile women with indication of use of contraceptive pills

Exclusion criteria

  • Fertile women with any surgical contraceptive method
  • Women in menopause
  • Diseases the forbidden the use of the drug

Treatment and study plan

gestoden 60 mcg

Drug

gestoden 60 mcg, once a day, administered in 24/4 regimen.

Other names: oral contraceptives, quality of life, gestodene and ethinyl estradiol

ethinylestradiol 15 mcg

Drug

ethinylestradiol 15 mcg, once a day, administered in 24/4 regimen

Other names: gestodene and ethinyl estradiol, quality of life, oral contraceptives

Primary outcomes

  1. Quality of life

    Time frame: eleven months

Secondary outcomes

  1. Quality of life in differents phases of menacme

    Time frame: eleven months

Sponsors and collaborators

Lead sponsor

Hospital Geral de Fortaleza

Other Gov

Collaborators

  • Medley S∕A Indústria Farmacêutica

Registry information

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Aug 3, 2010
Registry last updated
Aug 3, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.